XML 35 R22.htm IDEA: XBRL DOCUMENT v3.25.2
Investments
6 Months Ended
May 31, 2025
Equity Method Investments and Joint Ventures [Abstract]  
Investments Note 11. InvestmentsInvestments for which we exercise significant influence over the
investee are accounted for under the equity method of
accounting with our shares of the investees’ earnings recognized
in Other revenues. Equity method investments, including any
loans to the investees, are reported within Investments in and
loans to related parties.
$ in millions
May 31,
2025
November 30,
2024
Total Investments in and loans to related
parties ........................................................
$1,436.6
$1,385.7
Three Months Ended
May 31,
Six Months Ended
May 31,
$ in millions
2025
2024
2025
2024
Total equity method pickup
earnings recognized in Other
revenues ...................................
$8.1
$28.5
$15.2
$37.2
The following presents summarized financial information about
our significant equity method investees. For certain investees, we
receive financial information on a lag and the summarized
information provided for these investees is based on the latest
financial information available as of May 31, 2025, November 30,
2024 and May 31, 2024.
Jefferies Finance
Jefferies Finance, our 50/50 joint venture with Massachusetts
Mutual Life Insurance Company (“MassMutual”) structures,
underwrites and syndicates primarily senior secured loans to
corporate borrowers; and manages proprietary and third-party
investments in both broadly syndicated and direct lending loans.
In connection with its Leveraged Finance business, loans are
originated primarily through our investment banking efforts and
Jefferies Finance typically syndicates to third-party investors
substantially all of its arranged volume through us. The Asset
Management business is a multi-strategy private credit platform
that manages proprietary and third-party capital across
commingled funds, funds-of-one, separately managed accounts,
business development companies, CLOs and levered balance
sheet funds. Broadly syndicated loan investments are sourced
through transactions arranged by Jefferies Finance and third-
party arrangers and managed through its subsidiary, Apex Credit
Partners LLC. Direct lending investments are primarily sourced
through us. Jefferies Finance and its subsidiaries that are
involved in investment management are registered investment
advisers with the SEC.
At May 31, 2025, we and MassMutual each had equity
commitments to Jefferies Finance of $750.0 million, for a
combined total commitment of $1.5 billion. The equity
commitment is reduced quarterly based on our share of any
undistributed earnings from Jefferies Finance and the
commitment is increased only to the extent the share of such
earnings are distributed. At May 31, 2025, our unfunded
commitment to Jefferies Finance was $15.4 million. The
investment commitment is scheduled to expire on March 1, 2026
with automatic one year extensions absent a 60 day termination
notice by either party.
Jefferies Finance has executed a Secured Revolving Credit
Facility with us and MassMutual, to be funded equally, to support
loan underwritings by Jefferies Finance, which bears interest
based on the interest rates of the related Jefferies Finance
underwritten loans and is secured by the underlying loans funded
by the proceeds of the facility. The total Secured Revolving Credit
Facility is a committed amount of $500.0 million at May 31, 2025.
Advances are shared equally between us and MassMutual. The
facility is scheduled to mature on March 1, 2026 with automatic
one year extensions absent a 60 day termination notice by either
party. At May 31, 2025, our $250.0 million commitment was
undrawn.
Activity related to the facility:
Three Months Ended
May 31,
Six Months Ended
May 31,
$ in millions
2025
2024
2025
2024
Unfunded commitment fees .........
$0.3
$0.3
0.6
0.6
Selected financial information for Jefferies Finance:
$ in millions
May 31,
2025
November 30,
2024
Total assets ....................................................
$6,073.6
$5,762.6
Total liabilities ................................................
4,732.8
4,415.6
Total mezzanine equity .................................
13.9
14.4
$ in millions
May 31,
2025
November 30,
2024
Our total investment balance .......................
$663.5
$666.3
Three Months Ended
May 31,
Six Months Ended
May 31,
$ in millions
2025
2024
2025
2024
Net earnings (losses)
attributable to members ..........
$0.1
$40.2
$(1.6)
$39.3
Activity related to our other transactions with Jefferies Finance:
Three Months Ended
May 31,
Six Months Ended
May 31,
$ in millions
2025
2024
2025
2024
Origination and syndication fee
revenues (1) ............................
$58.4
$74.9
$118.6
$127.3
Origination fee expenses (1) .....
13.9
9.7
32.4
24.6
CLO placement and structuring
fee revenues (2) ....................
1.3
0.3
1.5
0.3
Placement and referral fees (3)
9.4
0.4
10.0
0.9
Asset management fee
revenues (4) .............................
7.5
7.5
Service fee revenues (5) .............
22.7
20.8
77.1
65.7
(1)We engage in the origination and syndication of loans underwritten by
Jefferies Finance. In connection with such services, we earned fees, which are
recognized in Investment banking revenues. In addition, we paid fees to
Jefferies Finance in respect of certain loans originated by Jefferies Finance,
which are recognized as Business development expenses.
(2)We act as a placement and/or structuring agent for CLOs managed by
Jefferies Finance, for which we recognized fees and are included in
Investment banking revenues.
(3)We receive fees from Jefferies Finance, which are recognized in Commissions
and other fees, in connection with placement and referral activities.
(4)Under a fee and revenue sharing agreement with Jefferies Finance, we receive
fees which are included in Asset management fees and revenues.
(5)Under a service agreement, we charge Jefferies Finance for various
administrative services provided.
In connection with non-U.S. dollar loans originated by Jefferies
Finance to borrowers who are investment banking clients of ours,
we have entered into an agreement to indemnify Jefferies
Finance with respect to any foreign currency exposure.
Receivables from Jefferies Finance, included in Other assets,
were $0.3 million and $1.9 million at May 31, 2025 and
November 30, 2024, respectively, and payables to Jefferies
Finance, included in Accrued expenses and other liabilities, were
$0.7 million at May 31, 2025. Additionally, a payable to Jefferies
Finance, related to cash deposited with us and included in
Payables to customers, was $1.0 million and $13.7 million at
May 31, 2025 and November 30, 2024, respectively.
Berkadia
Berkadia is a commercial real estate finance and investment
sales joint venture that was formed by us and Berkshire
Hathaway Inc. We are entitled to receive 45.0% of the profits of
Berkadia. Berkadia originates commercial and multifamily real
estate loans that are sold to U.S. government agencies or other
investors with Berkadia retaining the servicing rights. Berkadia
also provides advisory services in connection with sales of
multifamily assets. Berkadia is a servicer of commercial real
estate loans in the U.S., performing primary, master and special
servicing functions for U.S. government agency programs and
financial services companies.
Commercial paper issued by Berkadia is supported by a
$1.50 billion surety policy issued by a Berkshire Hathaway
insurance subsidiary and corporate guaranty, and we have
agreed to reimburse Berkshire Hathaway for one-half of any
losses incurred thereunder. At May 31, 2025, the aggregate
amount of commercial paper outstanding was $1.47 billion.
Selected financial information for Berkadia:
$ in millions
May 31,
2025
November 30,
2024
Total assets ...................................................
$4,914.9
$4,963.2
Total liabilities ...............................................
3,557.0
3,515.6
Total noncontrolling interest .......................
391.8
502.1
$ in millions
May 31,
2025
November 30,
2024
Our total investment balance .......................
$437.7
$427.7
Three Months Ended
May 31,
Six Months Ended
May 31,
$ in millions
2025
2024
2025
2024
Net earnings attributable to
members ....................................
$44.2
$48.9
$82.0
$78.2
Three Months Ended
May 31,
Six Months Ended
May 31,
$ in millions
2025
2024
2025
2024
Distributions ....................................
$10.9
$2.9
$27.0
$6.7
At May 31, 2025 and November 30, 2024, we had commitments
to purchase $17.4 million and $21.8 million, respectively, of
agency CMBS from Berkadia.
Revenues from other transactions with Berkadia for the six
months ended May 31, 2025 were $0.1 million. Revenues and
expenses from other transactions with Berkadia for both the
three and six months ended May 31, 2024 were $0.3 million and
$0.4 million, respectively.
Real Estate Investments
Our real estate equity method investments primarily consist of
our equity interests in Brooklyn Renaissance Plaza and Hotel and
54 Madison. Brooklyn Renaissance Plaza is composed of a hotel,
office building complex and parking garage located in Brooklyn,
New York. We have a 25.4% equity interest in the hotel and a
61.3% equity interest in the office building and garage. Although
we have a majority interest in the office building and garage, we
do not have control, but only have the ability to exercise
significant influence on this investment. We are amortizing our
basis difference between the estimated fair value and the
underlying book value of Brooklyn Renaissance office building
and garage over the respective useful lives (weighted average life
of 39 years).
We own a 48.1% equity interest in 54 Madison, a fund that most
recently owned an interest in one real estate project and the fund
is in the process of being liquidated.
Selected financial information for our significant real estate
investments:
$ in millions
May 31,
2025
November 30,
2024
Total assets ....................................................
$316.2
$326.0
Total liabilities ................................................
476.5
484.7
May 31,
2025
November 30,
2024
Our total investment balance .......................
$98.0
$97.8
Three Months Ended
May 31,
Six Months Ended
May 31,
$ in millions
2025
2024
2025
2024
Net earnings (losses) ....................
$(3.3)
$(2.4)
$1.3
$0.1
Three Months Ended
May 31,
Six Months Ended May
31,
$ in millions
2025
2024
2025
2024
Distributions we received
from Brooklyn Renaissance
Office .......................................
$1.2
$
$1.2
$
JCP Fund V
We have limited partnership interests of 11% and 50% in Jefferies
Capital Partners V L.P. and Jefferies SBI USA Fund L.P. (together,
JCP Fund V”), respectively, which are private equity funds
managed by a team led by our President and which are in the
process of being fully liquidated. The amount of our investments
in JCP Fund V included in Financial instruments owned, at fair
value was $2.7 million and $2.9 million at May 31, 2025 and
November 30, 2024, respectively. We account for these
investments at fair value based on the NAV of the funds provided
by the fund managers. The following summarizes the results
from these investments which are included in Principal
transactions revenues:
Three Months Ended
May 31,
Six Months Ended
May 31,
$ in millions
2025
2024
2025
2024
Net gains (losses) from our
investments in JCP Fund V .....
$
$0.1
$(0.2)
$(0.2)
At both May 31, 2025 and November 30, 2024, we were
committed to invest equity of up to $85.0 million in JCP Fund V.
At both May 31, 2025 and November 30, 2024, our unfunded
commitment relating to JCP Fund V was $8.7 million. We do not
expect any further capital to be called by JCP Fund V.
The following is a summary of the Net change in net assets
resulting from operations for 100.0% of JCP Fund V, in which we
owned effectively 35.1% at May 31, 2025 of the combined equity
interests:
Three Months Ended
$ in millions
March 31,
2025
December 31,
2024
March 31,
2024
December 31,
2023
Net increase (decrease)
in net assets resulting
from operations (1) .....
$0.1
$(0.6)
$0.1
$(0.9)
(1)Financial information for JCP Fund V within our results of operations for the
three months and six months ended May 31, 2025 and 2024 is included based
on the periods presented.
Hildene
In July 2024, we invested $25.0 million in the Class A Common
Equity Units of Hildene Insurance Holdings, LLC (“Hildene
Insurance”), an investment fund with insurance exposures. On
March 1, 2025, we made an additional investment of
$75.0 million in Hildene Insurance, which resulted in an increase
of our effective ownership from 8.83% to 23.5%. The investment
is accounted for under the equity method with a carrying amount
of $104.2 million and $27.5 million at May 31, 2025 and
November 30, 2024, respectively.
Selected financial information for Hildene Insurance:
$ in millions
March 31,
2025 (1)
September 30,
2024 (1)
Total assets ...............................................................
$447.9
$304.2
Total liabilities ...........................................................
0.1
0.2
Total members’ equity .............................................
447.8
304.0
Three Months Ended (1)
$ in millions
March 31,
2025
December 31,
2024
Net increase in members’ equity resulting from
operations ................................................................
$27.5
$8.4
(1)Financial information for Hildene Insurance Holdings, LLC included in our
financial position at May 31, 2025 and November 30, 2024 is based on the
dates presented, and in our results of operations for the three and six months
ended May 31, 2025 is based on the periods presented.
ApiJect
We own shares that represent a 33.6% economic interest in
ApiJect at both May 31, 2025 and at November 30, 2024, which
are accounted for at fair value by electing the fair value option
available under U.S. GAAP, and are included within corporate
equity securities in Financial instruments owned, at fair value. At
both May 31, 2025 and November 30, 2024, the total fair value of
our total equity investment in common shares of ApiJect was
$116.1 million, which is classified within Level 3 of the fair value
hierarchy.
Additionally, we own warrants to purchase up to 950,000 shares
of common stock at any time or from time to time on or before
April 15, 2032, and we have a right to 1.125% of ApiJect’s future
revenues.
We also have a term loan agreement with a principal of ApiJect
for $23.3 million, which will mature on July 31, 2025. The loan is
accounted for at amortized cost and is reported within Other
assets. The loan has a fair value of $23.3 million at both May 31,
2025 and November 30, 2024, which would be classified as Level
3 in the fair value hierarchy.
Aircadia
In December 2023, Aircadia Leasing II LLC (“Aircadia”), a wholly
owned subsidiary, purchased airplanes and simultaneously
entered into a lease with the seller to lease the airplanes for a
term of 42 months. The transaction was accounted for as a sale
leaseback and the airplanes were recorded within Premises and
equipment at $57.7 million.
Three Months Ended
May 31,
Six Months Ended
May 31,
$ in millions
2025
2024
2025
2024
Operating lease income ................
$1.3
$5.6
$6.9
$9.4
Also in December 2023, we provided a loan to the seller for
$30.0 million, which was paid off on April 1, 2025. The loan was
accounted for at amortized cost and included within Investments
in and loans to related parties. We recognized interest income of
$0.2 million and $1.0 million on the loan during the three months
and six months ended May 31, 2025, respectively, and
$0.8 million and $1.4 million during the three months and six
months ended May 31, 2024, respectively. We also hold preferred
shares in the seller, which are accounted for at fair value in
Financial instruments owned with a fair value of $41.8 million
and $37.1 million at May 31, 2025 and November 30, 2024,
respectively, and are classified within Level 3 of the fair value
hierarchy.
In September 2024, we provided a €15.0 million loan, maturing in
November 2025, to an individual related to the seller, secured by
a privately owned aircraft and guaranteed by the individual. We
recognized interest income of $0.5 million and $0.9 million for
the three months and six months ended May 31, 2025,
respectively.
During 2024, we classified the airplanes related to the sale
leaseback transaction as held for sale. Effective with the
designation of the airplanes as held for sale, we suspended
recording depreciation on these assets. The airplanes are
included within Assets held for sale on our Consolidated
Statements of Financial Condition and had a carrying amount of
$51.9 million at November 30, 2024. During the second quarter of
2025, we agreed to sell the airplanes and we recognized a loss of
$12.8 million during the three months ended May 31, 2025. The
sale is expected to close in the third quarter of 2025.